A Lifecourse Map of Diseases in China
A Lifecourse Map of Common Diseases and Rare Diseases in China
1 other identifier
observational
40,000,000
1 country
1
Brief Summary
The purpose of this study is to form a chronological map of common diseases and rare diseases in Chinese population by determining the prevalence of different diseases in each age group.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Aug 2022
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2022
CompletedFirst Submitted
Initial submission to the registry
November 3, 2022
CompletedFirst Posted
Study publicly available on registry
November 10, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 31, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
July 31, 2024
CompletedNovember 10, 2022
November 1, 2022
12 months
November 3, 2022
November 3, 2022
Conditions
Outcome Measures
Primary Outcomes (2)
age-specific prevalence rate
Age-specific prevalence rate stratified by sex were calculated by dividing the number of incident cases with a current disease by the total number of people in the study population during that time period.
between January 1, 2017 and December 31, 2021
sex-specific prevalence rate
Sex-specific prevalence rate stratified by age for 10-year bands were calculated by dividing the number of incident cases with a current disease by the total number of people in the study population during that time period.
between January 1, 2017 and December 31, 2021
Secondary Outcomes (1)
total cost of hospitalization
between January 1, 2017 and December 31, 2021
Study Arms (1)
Hospitalized patients
The diseases were included based on the results of the preliminary data exploration and standardization according to ICD-10.
Interventions
Data analysis is based on a single database from the National Health Medical Data (North Center).
Eligibility Criteria
All inpatients within the period of January 1, 2017 to December 31, 2021.
You may qualify if:
- All inpatients within the period of January 1, 2017 to December 31, 2021.
- Patients with discharge diagnosis.
- Patients with accurate gender and age records.
You may not qualify if:
- Morbidity and mortality due to external causes, i.e. injuries, poisonings and other adverse events due to external environment and accidents.
- Pregnancy-related conditions.
- Symptoms, signs, abnormal clinical and laboratory findings.
- Traditional Chinese Medicine diagnosis records.
- Patients with incorrect or missing disease codes.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Shandong Universitylead
- National Health Medical Data (North Center)collaborator
Study Sites (1)
Shandong University
Jinan, Shandong, 250012, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Head of department of clinical pharmacy and pharmacology
Study Record Dates
First Submitted
November 3, 2022
First Posted
November 10, 2022
Study Start
August 1, 2022
Primary Completion
July 31, 2023
Study Completion
July 31, 2024
Last Updated
November 10, 2022
Record last verified: 2022-11